Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio-Reference-Cited by-同舟云学术

Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio

Published:2024-08 Issue:3 Volume:167 Page:627-628
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Benech Nicolas^ORCID,Cassir Nadim,Galperine Tatiana,Alric Laurent,Scanzi Julien,Sokol Harry,Benech Nicolas,Cassir Nadim,Alric Laurent,Melchior Chloé,Mosca Alexis,Joly Anne-Christine,Kapel Nathalie,Barbut Frédéric,Galperine Tatiana,Pigneur Bénédicte,Davido Benjamin,Schneider Stéphane,Briot Thomas,Wasiak Mathieu,Nebad Biba,Batista Rui,Mosca Alexis,Bleibtreu Alexandre,Scanzi Julien,Sokol Harry,Sintes Rachel,Corriger Alexandrine,Flet Laurent,Perlemuter Gabriel,Ahloulay Mina,Yaye Hassane Sadou,De Rougemont Alexis,Olivier Emmanuelle,Burucoa Christophe,Gobert Jean-gérard,Landman Cecilia,Vignal Luc,Joly Francisca,Ravinet Aurélie,Bellanger Agnès,Sabate Jean-Marc,Humbert Caroline,Wisnewsky Judith Aron,Charpentier Chloé,Moreno-Sabater Alicia,Takoudju Céline,Poirier Philippe,Tanne Florence,De Lastours Victoire,Stampfli Camille

Publisher

Elsevier BV

Reference8 articles.

1. AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases

2. Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease

3. Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals

4. Short- and long-term effects of oral vancomycin on the human intestinal microbiota

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply;Gastroenterology;2024-08